Verlag:
Elsevier Unsere-Artikel-Nr.: EDW67K8
EAN: 9780128223185
Erhältlich:
Nicht auf Lager
Zustellung: Mo, 12.10.2026
Versand: Kostenlos
-18.9 %
CHF 200.–
CHF 162.12
Beschreibung
Monoclonal antibodies (mAbs) are naturally occurring complex biomolecules. New engineering methods have turned mAbs into a leading therapeutic modality for addressing immunotherapeutic challenges and led to the rise of mAbs as the dominant class of protein therapeutics. mAbs have already demonstrated a great potential in developing safe and reliable treatments for complex diseases and creating more affordable healthcare alternatives. Developing mAbs into well-characterized antibody therapeutics that meet regulatory expectations, however, is extremely challenging. Obstacles to overcome include the determination and development of physiochemical characteristics such as aggregation, fragmentation, charge variants, identity, carbohydrate structure, and higher-order structure (HOS). This book dives deep into mAbs structure and the array of physiochemical testing and characterization methods that need to be developed and validated to establish a mAb as a therapeutic molecule. The main focus of this book is on physiochemical aspects, including the importance of establishing quality attributes such as glycosylation, primary sequence, purity, and HOS and elucidating the structure of new antibody formats by mass spectrometry. Each of the aforementioned quality attributes has been discussed in detail; this will help scientists in researching and developing biopharmaceuticals and biosimilars to find practical solutions to physicochemical testing and characterization.
Spezifikationen
Sprache
- Englisch
Autor
- Harleen Kaur
- Dietmar Reusch
Erscheinungsjahr
- 2021
Format
- Buch (Softcover)
Anzahl Seiten
- 258